Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

(iStock)
April 22, 2026

Liquid biopsy predicts response to breast cancer immunotherapy

This minimally invasive and cost-effective alternative to tissue biopsy offers “an accessible tool for tailoring treatment strategies in breast cancer,” researchers reported April 22 in the journal Science Translational Medicine.

By Bill Snyder
April 14, 2026

Genomic testing finds a higher prevalence of high-risk breast cancer in Black women

These findings highlight the critical need for tumor genomic testing for all patients to identify those with high-risk tumors, which occur more frequently in Black women, and which require more aggressive treatment to prevent recurrence.

By Bill Snyder
April 9, 2026

How robotic bronchoscopy helped a Georgia man avoid unnecessary lung surgery

Oncologist Mohamed Shanshal, MD, said robotic bronchoscopy significantly improves getting patients the appropriate treatment as soon as possible, reducing their anxiety and improving care.

By Jill Clendening
March 10, 2026

Lung cancer conference set for May 8

Vanderbilt-Ingram Cancer Center and the Vanderbilt Lung Institute will host “The Future of Lung Cancer Care,” a one-day educational event scheduled for May 8 from 8:30 a.m. to 2:30 p.m. at the Nashville Marriott at Vanderbilt University.

By Tom Wilemon
February 18, 2026

Patient with melanoma receives tumor-infiltrating lymphocyte therapy

The highly personalized treatment is currently approved for patients with advanced stages of melanoma whose tumors have grown despite immunotherapies and/or targeted therapies.

By Tom Wilemon
Before being sedated, Aaron Davis gives a thumbs up with his surgical team. (photo by Donn Jones)
February 12, 2026

Vanderbilt Health celebrates milestone for novel histotripsy procedure 

Appealing to patients for its noninvasive nature, it avoids many of the traditional drawbacks of surgeries that use incisions, including pain management. 

By Evan Dorian